23 June 2025 in The Journal of Clinical Endocrinology & Metabolism
Context: Biochemical screening for endocrine hypertension may be complex; the known presence of an adrenal mass markedly increases the pretest probability for adrenal hypertension and may inform diagnostic efforts. Objective: Model the potential incidence of adrenal masses that may be detected by routine adrenal imaging in patients with suspected endocrine hypertension. Design: Retrospective cohort study. Setting: Provincial administrative and clinical databases for radiology and biochemistry, Alberta, Canada. Participants: Patients with hypertension and any measurement of aldosterone-renin ratio (ARR), 2012 to 2019. Main Measures: Radiology report of any computed tomography or magnetic resonance imaging abdomen performed for any reason 0 to 12 years following ARR. Patients with any pre-ARR imaging data between 2002 and 2024 were excluded. The presence of adrenal mass, size, and density were recorded and stratified by imaging indication. Results: Of 6942 unique hypertension patients with ARR, 1462 (21%) had imaging done at some point after ARR, 912 (62.4%) for indications unrelated to hypertension/adrenal and at a median 771 days (69-1577) post ARR. The incidence rate estimate was 7.2% (5.6-9.2%) of scans showed adrenal mass, median 1.4 cm (1.1-2.3), a rate well above the modern series of adrenal incidentaloma prevalence in unselected adults. The number needed to screen in this population was 14 (11-18) to detect an adrenal mass without a priori indication for adrenal imaging. Conclusion: Among patients screened for PA but without prior or subsequent directed adrenal imaging, 1 in 14 were later found to have an adrenal mass on imaging done for other indications. Given the impact on pretest probability for endocrine hypertension and further investigation steps, routine adrenal imaging might be considered whenever PA suspicion is high.
1 May 2026 in Hypertension
BACKGROUND: Prior retrospective studies of aldosterone-renin ratio (ARR) measures were confounded by selection bias. METHODS: To define ARR sensitivity independent of case definition, administrative health and diagnostic imaging repositories in Alberta, Canada, were used to construct a 5-component definition for primary aldosteronism (PA) for the most easily recognizable cases. Components included hypertension, hypokalemia, adrenal mass, suppressed renin, and nonsuppressed aldosterone. ARR was omitted from the definition, permitting independent evaluation of the ARR using receiver operating characteristic curve analysis. The definition was validated by adrenal vein sampling and surgical outcomes. RESULTS: Of 931 adrenal vein sampling patients, 19.2% met the 5-component PA case definition; of these, 86.8% had unilateral disease, and of the 76.8% who underwent surgery, 91.2% achieved complete biochemical response. Between 2012 and 2019, 6717 patients with hypertension had ARR measured; 60.9% had computed tomography or magnetic resonance imaging performed for any reason. The prevalence of the 5-component PA cases was 4.8% by direct renin concentration and 6.6% by plasma renin activity. The area under the receiver operating characteristic curve for the ARR was 0.84 (0.81–0.86) and 0.82 (0.78–0.85) when direct renin concentration and plasma renin activity were used. The 90% sensitivity ARR threshold for the 5-component PA case definition was 26 pmol/mIU (direct renin) and 350 pmol/ng per mL/h (renin activity), with specificities of 60% and 56%. At 5% prevalence rates, positive predictive values were 11% and 10%. Commonly recommended ARR screening thresholds of 70 pmol/mIU or 550 pmol/ng per mL/h had sensitivities of 68% and 82%, respectively, for a surgically relevant PA phenotype. CONCLUSIONS: Current ARR thresholds have low-to-moderate sensitivity for cases of PA where adrenal vein sampling and surgery are strong considerations.
6 February 2026 in medRxiv
Background: Primary aldosteronism(PA) screening is recommended but disease prevalence exceeds the availability of adrenal vein sampling(AVS). Methods: An AVS optimal allocation tool for health systems was developed using administrative data and AVS registries from Calgary and Taiwan. Four easily-definable phenotypes of PA based on an elevated aldosterone-renin-ratio (ARR), and the presence/absence of hypokalemia or adrenal mass were identified, representing progressively severe PA and stepwise increasing rates of AVS-defined lateralization. Using supply-and-demand principles, a customizable, web-based tool was developed that considers PA referral volume, PA phenotype prevalence, maximum AVS available/year, AVS success rate, and desired rate of finding unilateral disease. Results: The most prevalent phenotype of PA was characterized by an elevated ARR and hypokalemia but no adrenal mass (41.9 [39.9–43.9]%); hypokalemia and adrenal mass accounted for (15.6[14.4-16.9]%) of cases. There was a progressive increase in AVS lateralization rate with increasing severity of phenotype observed in both the Calgary and Taiwan data, ranging from (20-39%) in those with PA without hypokalemia or adrenal mass to (70-90%) in those with hypokalemia and adrenal mass. After accounting for institution-specific lateralization rates and allowing for system-level differences in high- and low-volume PA referrals, and high- and low AVS availability, the customizable AVS allocation tool was able to generate individualized strategies ranging from restrictive (exclusive reservation of AVS for cases with hypokalemia and adrenal mass) to more inclusive strategies (assigning a proportion of AVS allocation to less severe PA cases). Conclusions: An AVS allocation tool that uses common, simple, and globally available PA case data may assist in health system AVS program case allocation for maximum equity and wait-list control. GRAPHICAL
25 September 2026 in JCEM Case Reports
Spontaneous intranodular thyroid hemorrhage (ITH) is a rare clinical occurrence. Previous case reports describe sudden severe neck swelling, often resulting in life-threatening respiratory distress that may necessitate urgent surgical intervention. Although thought to be rare, the true incidence of ITH is unknown, and ITH should be considered in the differential diagnosis of patients presenting with acute neck symptoms, due to its potential to cause airway compromise. We illustrate a more subtle presentation of ITH in a case series of 3 female patients with acute neck swelling and pain: a 34-year-old with no prior history of thyroid disease, a 40-year-old with a history of hypothyroidism, and a 49-year-old with a preexisting history of thyroid nodules. All 3 patients had ultrasounds demonstrating spontaneous ITH which resolved with conservative management. In noncompressive lesions, conservative management with watchful waiting and surveillance ultrasounds is a reasonable approach.